Privia Health Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Privia Health Group, Inc. (PRVA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 21.58 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 16.04K shares, a 123.69% increase year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 5.54K shares, a 158.91% increase year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 1.03K shares, a 10.10% decline year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 8.39K shares, a 53.03% decline year-over-year.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 18.73K shares, a 45.44% decline from fiscal 2024.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 34.33K shares, a 86.36% decline from fiscal 2023.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 251.71K shares, a 59.85% increase from fiscal 2022.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 157.46K shares, a 22.34% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 16.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 21.58K shares 10-Q · filed 2026-08-06 | 22.61K shares derived: sum of 3 quarters · filed 2026-08-06 | 31.00K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 5.54K shares 10-Q · filed 2026-05-07 | 6.57K shares derived: sum of 2 quarters · filed 2026-05-07 | 14.96K shares derived: sum of 3 quarters · filed 2026-05-07 | 22.13K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 1.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 9.42K shares derived: sum of 2 quarters · filed 2026-02-27 | 16.59K shares derived: sum of 3 quarters · filed 2026-02-27 | 18.73K shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 8.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 15.56K shares derived: sum of 2 quarters · filed 2025-11-06 | 17.70K shares 10-Q · filed 2025-11-06 | 18.85K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | 7.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 9.31K shares 10-Q · filed 2025-08-07 | 10.46K shares derived: sum of 3 quarters · filed 2026-02-27 | 28.32K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | 2.14K shares 10-Q · filed 2025-05-08 | 3.29K shares derived: sum of 2 quarters · filed 2026-02-27 | 21.15K shares derived: sum of 3 quarters · filed 2026-02-27 | 31.07K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | 1.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 19.01K shares derived: sum of 2 quarters · filed 2026-02-27 | 28.93K shares derived: sum of 3 quarters · filed 2026-02-27 | 34.33K shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 17.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 27.78K shares derived: sum of 2 quarters · filed 2024-11-07 | 33.18K shares 10-Q · filed 2024-11-07 | 50.06K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 9.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 15.32K shares 10-Q · filed 2024-08-08 | 32.20K shares derived: sum of 3 quarters · filed 2026-02-27 | 70.99K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | 5.40K shares 10-Q · filed 2024-05-09 | 22.29K shares derived: sum of 2 quarters · filed 2026-02-27 | 61.07K shares derived: sum of 3 quarters · filed 2026-02-27 | 116.95K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | 16.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 55.67K shares derived: sum of 2 quarters · filed 2026-02-27 | 111.55K shares derived: sum of 3 quarters · filed 2026-02-27 | 251.71K shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 38.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 94.67K shares derived: sum of 2 quarters · filed 2023-11-03 | 234.83K shares 10-Q · filed 2023-11-03 | 240.90K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 55.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 196.04K shares 10-Q · filed 2023-08-03 | 202.11K shares derived: sum of 3 quarters · filed 2025-02-27 | 238.28K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 140.16K shares 10-Q · filed 2023-05-04 | 146.23K shares derived: sum of 2 quarters · filed 2025-02-27 | 182.40K shares derived: sum of 3 quarters · filed 2025-02-27 | 247.90K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 6.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 42.24K shares derived: sum of 2 quarters · filed 2025-02-27 | 107.74K shares derived: sum of 3 quarters · filed 2025-02-27 | 157.46K shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 36.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 101.66K shares derived: sum of 2 quarters · filed 2022-11-10 | 151.39K shares 10-Q · filed 2022-11-10 | 181.62K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 65.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 115.22K shares 10-Q · filed 2022-08-11 | 145.45K shares derived: sum of 3 quarters · filed 2024-02-27 | 215.54K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 49.73K shares 10-Q · filed 2022-05-12 | 79.95K shares derived: sum of 2 quarters · filed 2024-02-27 | 150.05K shares derived: sum of 3 quarters · filed 2024-02-27 | 174.45K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 30.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 100.32K shares derived: sum of 2 quarters · filed 2024-02-27 | 124.72K shares derived: sum of 3 quarters · filed 2024-02-27 | 202.77K shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 70.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 94.50K shares derived: sum of 2 quarters · filed 2021-11-08 | 172.55K shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 24.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 102.45K shares 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 78.05K shares 10-Q · filed 2021-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |